Park Ha Biological Technology (PHH) - רווח סופי
Park Ha Biological Technology (PHH) logistics base and packaging capacities are functioning seamlessly due to systematic maintenance. Patent protection for dietary supplement and cosmetic formulas ensures the stability of its positions within Chinese retail. The company's operating result demonstrates current dynamics, where the indicator value is -0.02. The integration of AI analytics and IT solutions confirms a high potential for business modernization, as clearly illustrated by this chart.
פילוחים אנליטיים ודוחות נתונים של חברת ir.parkha.cn (PHH)
Stable net margin dynamics serve as a fundamental criterion for the issuer's long-term reliability, allowing market noise to be separated from actual business efficiency. The total profit of Park Ha Biological Technology (PHH) on this chart reflects the final cash flow after all expenses, which, in the case of Park Ha Biological Technology, confirms the profitability of selling dietary supplements and cosmetics through Chinese pharmacy chains and digital channels.